Device Trial Radar · NCT06614582
Long-term Evaluation of Nasopharyngeal Airway in Hypotonia
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
40
Planned (sponsor's estimate)
Start
Oct 23, 2024
Primary completion
Oct 2028
Study completion Oct 2028
Sponsor
- Lead sponsor
- University of MichiganAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 26, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 3 years, up to 23 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This research is studying the long term use of a nasal airway device (self-supporting nasopharyngeal airway; "ssNPA") in children with hypotonic upper airway obstruction to learn about its effectiveness and tolerability as a treatment for obstructive sleep apnea.
Conditions
- Hypotonia, Muscle
- Obstructive Sleep Apnea
- Nasal Airway Obstruction
Interventions
Self-Supporting Nasopharyngeal Airway (ssNPA)Device
The ssNPA device is a flexible, medical-grade silicone, nasal tube that is self-inserted into the airway through one nostril and worn during the night. It can also be used during the day. The device works by supporting collapsed airway muscles and keeping the airway open. In addition to wearing the device, study team members will call monthly and collect certain data, and medical information and participants will be asked to have a sleep study at the 12-month visit.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Obstructive sleep apnea (OSA) severity measured by the apnea/hypopnea index (AHI) assessed by overnight polysomnographyTime frame: Approximately 1 year
- Long term device tolerability assessed by self-report from caregiversTime frame: 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Michigan
Ann Arbor, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.